SGLT2 Inhibitors (e.g., Farxiga, Jardiance)

Type: drug

Status: FDA Approved

Developer: AstraZeneca (Farxiga), Eli Lilly/Boehringer Ingelheim (Jardiance)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026